These findings suggest that B. thetaiotaomicron and acetic acid treatment may modulate the expression of immune-related genes, specifically CD86, NOS2, CD163, and ARG1, in HCC mouse tumor tissues, potentially influencing the immune microenvironment and tumor progression. The gene discussed is ARG1; the disease is hepatocellular carcinoma.